The new obesity drugs work, but it's a dilemma when people have to stop taking them
New Obesity Drugs: Cure or Temporary Fix?
Jonathan Meyers, who has a history of weight fluctuations, found success with a new GLP-1 agonist drug, Zepbound, losing 35 pounds and overcoming constant hunger. However, due to supply shortages, he struggles to maintain access to the medication, reflecting a common issue among users of these obesity drugs. Many individuals face the dilemma of potential weight regain after discontinuing these drugs due to various reasons like cost, side effects, or lack of availability, highlighting the chronic nature of obesity treatment and the challenges in managing it without continuous medication.
How did Jonathan Meyers manage his weight before using Zepbound, and what was his experience with the drug?
Before using Zepbound, Jonathan Meyers had tried various diets like Keto, high protein, low fat, and calorie-restrictive diets but always regained the weight he lost. He experienced success and failures with these diets but could not maintain his weight loss.
After starting Zepbound, Meyers lost 35 pounds and felt free from hunger. He found that the drug suppressed his "food noise" - the compulsion to eat - which allowed him to consume less and exercise more. However, due to the drug's short supply, Meyers had to search for alternatives, eventually opting for a similar drug from a compound pharmacy in Florida. Despite some mixed results and uncertainties, Meyers found the experience worthwhile in his effort to manage his weight and associated health risks.
What difficulties did Meyers face in obtaining Zepbound, and how did he address these challenges?
Jonathan Meyers, a digital strategist at an environmental nonprofit, faced difficulties in obtaining Zepbound due to its short supply and high demand. Meyers had to search extensively for the medication and even had family members in Maine ship the drug to him in Maryland. However, when he could no longer find Zepbound, he turned to a compound pharmacy in Florida that sold a similar drug. With his doctor's cautious approval, Meyers began using the substitute medication despite uncertainties regarding its ingredients and potential side effects.